ET-3 Activators
The chemical class termed ET-3 Activators encompasses a diverse range of compounds that, while not directly interacting with ET-3 or its receptors, exert an influence on the cellular and molecular pathways that regulate ET-3 expression or activity. This class includes various agents such as adenylyl cyclase activators, protein kinase C activators, nitric oxide donors, beta-adrenergic agonists, calcium channel blockers, angiotensin receptor blockers, phosphodiesterase inhibitors, alpha-2 adrenergic receptor antagonists, nicotinic acetylcholine receptor agonists, and TRPV1 receptor activators.
Each of these compounds, though diverse in their primary mechanisms of action, shares the common feature of being able to modulate cellular signaling pathways that indirectly impact the expression, release, or activity of ET-3. For instance, compounds that increase intracellular cAMP levels, such as forskolin and isoproterenol, can enhance ET-3 expression by activating PKA, which may then influence transcription factors that regulate the ET-3 gene. Similarly, calcium channel blockers like amlodipine and nifedipine, by altering intracellular calcium dynamics, can modulate the function of endothelin receptors, thereby affecting ET-3 activity. Nitric oxide donors, represented by sodium nitroprusside, demonstrate the interplay between vasodilatory pathways and endothelin system regulation. Angiotensin receptor blockers like valsartan and losartan highlight the intricate connections between the renin-angiotensin system and ET-3 regulation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog known to activate protein kinase C (PKC). PKC activation can lead to the phosphorylation of various proteins that are part of the signaling pathways influencing endothelin expression. For instance, PKC-mediated phosphorylation may enhance transcription factors regulating ET-3 gene expression. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, increasing intracellular cAMP levels. Elevated cAMP can stimulate protein kinase A (PKA), which in turn may influence transcription factors involved in ET-3 expression or modulate endothelin receptor sensitivity. | ||||||
Sodium nitroprusside dihydrate | 13755-38-9 | sc-203395 sc-203395A sc-203395B | 1 g 5 g 100 g | $43.00 $85.00 $158.00 | 7 | |
As a nitric oxide donor, sodium nitroprusside can induce vasodilation. Nitric oxide can modulate endothelin receptor activity and expression, thereby indirectly affecting ET-3 signaling pathways. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a β-adrenergic agonist which, through G protein-coupled receptor activation, can increase intracellular cAMP. This elevation can modulate ET-3 expression through PKA-dependent mechanisms. | ||||||
Amlodipine | 88150-42-9 | sc-200195 sc-200195A | 100 mg 1 g | $74.00 $166.00 | 2 | |
Amlodipine, a calcium channel blocker, influences calcium influx. Altered intracellular calcium levels can affect endothelin receptor signaling and potentially modify ET-3 expression. | ||||||
Valsartan | 137862-53-4 | sc-220362 sc-220362A sc-220362B | 10 mg 100 mg 1 g | $40.00 $92.00 $122.00 | 4 | |
Valsartan, an angiotensin II receptor blocker, may indirectly influence ET-3 levels by modulating the renin-angiotensin system, known to interact with the endothelin system. | ||||||
Losartan | 114798-26-4 | sc-353662 | 100 mg | $130.00 | 18 | |
Similar to Valsartan, Losartan as an angiotensin receptor blocker could affect ET-3 expression through its influence on the renin-angiotensin-aldosterone system. | ||||||
Nifedipine | 21829-25-4 | sc-3589 sc-3589A | 1 g 5 g | $59.00 $173.00 | 15 | |
As a calcium channel blocker, Nifedipine's alteration of calcium signaling can indirectly influence ET-3 expression or activity by modulating endothelin receptor functions. | ||||||
Caffeine | 58-08-2 | sc-202514 sc-202514A sc-202514B sc-202514C sc-202514D | 50 g 100 g 250 g 1 kg 5 kg | $33.00 $67.00 $97.00 $192.00 $775.00 | 13 | |
Caffeine inhibits phosphodiesterases, leading to increased cAMP levels. This rise in cAMP may impact ET-3 expression via PKA activation and subsequent modulation of transcription factors. | ||||||
Yohimbine hydrochloride | 65-19-0 | sc-204412 sc-204412A sc-204412B | 1 g 5 g 25 g | $51.00 $171.00 $530.00 | 2 | |
Yohimbine, an alpha-2 adrenergic receptor antagonist, can modulate sympathetic nervous system activity. This modulation may indirectly influence ET-3 expression or activity within the vascular system. | ||||||